Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Novo Holdings
AddedFeb 13, 2024
UpdatedJun 28, 2026
Novo Holdings

Novo Holdings

Operating

Danish-based Novo Holdings A/S, a wholly-owned subsidiary of the Novo Nordisk Foundation.

Location
Hellerup, Capital Region of Denmark, DK
Founded
1999
Firm
Compare
Portfolio
Employees
News
Website

Novo Holdings A/S, based in Denmark, is the holding and investment company of the Novo Nordisk Foundation. The firm manages a diverse investment portfolio with a long-term return perspective, focusing on various stages including Series A, B, C, D, and beyond. Novo Holdings is the controlling shareholder of Novo Nordisk and Novozymes and invests across multiple sectors, primarily in life sciences and healthcare.

Notable portfolio companies include Akebia Therapeutics, Aligos Therapeutics, and Tempus Labs. Key partners and decision-makers leverage their extensive industry experience to guide investments. Novo Holdings is known for its strategic support and value-add services to portfolio companies, including leveraging its deep industry connections and expertise to foster growth and innovation.

Novo Holdings - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments108
Current Portfolio Count64
Total Portfolio Exits6

Top Investment Stages

Series B30 (34.5%)
Series A29 (33.3%)
Series C16 (18.4%)
Series Unknown7 (8.0%)
Private Equity5 (5.7%)

Stage Mix

Series B 34%Series A 33%Series C 18%Series Unknown 8%Private Equity 6%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Elo Life Systems logo

Elo Life Systems

Cleveland Diagnostics logo

Cleveland Diagnostics

Revagenix logo

Revagenix

Claris Biotherapeutics logo

Claris Biotherapeutics

OnCusp Therapeutics logo

OnCusp Therapeutics

Nalu Medical logo

Nalu Medical

EnergyRe logo

EnergyRe

Terremoto Biosciences logo

Terremoto Biosciences

MapLight Therapeutics logo

MapLight Therapeutics

Avalyn Pharma logo

Avalyn Pharma

Clever Care Health Plan logo

Clever Care Health Plan

Spruce Biosciences logo

Spruce Biosciences

Metagenomi logo

Metagenomi

Iecure logo

Iecure

Breye Therapeutics logo

Breye Therapeutics

Kate Farms logo

Kate Farms

Vestaron logo

Vestaron

Inspirna logo

Inspirna

Nuvig Therapeutics logo

Nuvig Therapeutics

Invetx logo

Invetx

Rondo Therapeutics logo

Rondo Therapeutics

Biomason logo

Biomason

Verana Health logo

Verana Health

Biomilq logo

Biomilq

Genomatica logo

Genomatica

Novo Holdings - Similar Investment Firms

Novo Ventures logo

Novo Ventures

Novo Holding logo

Novo Holding

novoholding.com

Novo Seeds logo

Novo Seeds

Novator Partners logo

Novator Partners

novator.co.uk

Vargas Holding logo

Vargas Holding

vargasholding.se

A.P. Moller Holding logo

A.P. Moller Holding

apmoller.com

Novartis Venture Fund logo

Novartis Venture Fund

nvfund.com

MSA Novo logo

MSA Novo

msanovo.com

Northwell Holdings logo

Northwell Holdings

northwell.edu

Vækstfonden logo

Vækstfonden

eifo.dk

Novalis LifeSciences logo

Novalis LifeSciences

Founders logo

Founders

founders.as

Nordic Capital logo

Nordic Capital

nordiccapital.com

Repair Impact Fund logo

Repair Impact Fund

Novo Capital logo

Novo Capital

Novo Holdings - Classification

Also Known As
  • Novo Holdings A/S
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
ISIC
  • 6499Other financial service activities, except insurance and pension funding activities, n.e.c.
  • 6810Real estate activities with own or leased property
Show 5 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
SIC
  • 6000Depository Institutions
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end